Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$0.54 - $1.41 $3,183 - $8,311
-5,895 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$4.27 - $6.97 $11,661 - $19,035
2,731 Added 86.31%
5,895 $30,000
Q3 2021

Nov 12, 2021

BUY
$5.31 - $8.25 $5,761 - $8,951
1,085 Added 52.19%
3,164 $18,000
Q2 2021

Aug 17, 2021

BUY
$6.81 - $9.23 $14,157 - $19,189
2,079 New
2,079 $17,000

Others Institutions Holding AXDX

About Accelerate Diagnostics, Inc


  • Ticker AXDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 99,059,904
  • Market Cap $191M
  • Description
  • Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...
More about AXDX
Track This Portfolio

Track Itau Unibanco Holding S.A. Portfolio

Follow Itau Unibanco Holding S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Itau Unibanco Holding S.A., based on Form 13F filings with the SEC.

News

Stay updated on Itau Unibanco Holding S.A. with notifications on news.